臨床試験

A Clinical Investigation to Evaluate Microwave Imaging Via MammoWave® in a Population-based Screening Program for Early Breast Cancer Detection

NCT: NCT06291896 · RECRUITING

NCT識別子NCT06291896

ステータスRECRUITING

開始日2024-03-15

完了2026-12-15

SponsorUmbria Bioengineering Technologies (INDUSTRY)

First posted2024-03-04

Last updated2026-05-13

概要

This is an open, multicentric, interventional, prospective, non-randomized clinical investigation. The first aim of the study is to confirm that MammoWave reaches sensitivity\>75% and specificity\>90% in breast cancer (BC) detection on 10.000 volunteers undergoing regular screening programs.

公式ソース

ClinicalTrials.govで見る →

データはClinicalTrials.gov APIから取得しています。最新のステータスは公式記録をご確認ください。